Company Analysis

Inspire Medical Systems, Inc. (INSP)

NYSE: INSP · Surgical & Medical Instruments & Apparatus · Golden Valley, MN · filing with the SEC since 2014
Grade7.5
◀ Past 7.9● Present 8.0▶ Future 6.3

Who owns Inspire Medical Systems, Inc.

As filed with the SEC
Holders of 5% or more
7
Blackrock, Inc. holds 14.4% of Common Stock, as its SCHEDULE 13G/A filed Jul 28, 2026 says.
Directors and officers
17
report now, of 28 people on the record since 2018. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 7 named at left.
Holders of 5% or moreshare of the class, as filed
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 28, 2026 · Common Stock · 11.3% in Oct 17, 2025
14.4%
Wellington Management Group LLP
SCHEDULE 13G/A · filed May 15, 2026 · Common Stock · 7.6% in Feb 10, 2026
8.8%
Vanguard Portfolio Management
SCHEDULE 13G/A · filed Jul 31, 2026 · Common Stock · 5.71% in Apr 29, 2026
7.37%
Soleus Capital Master Fund, L.P.
SCHEDULE 13G/A · filed Aug 13, 2026 · Common Stock, $0.001 par value per share · 5.1% in May 27, 2026
6.7%
AQR Capital Management, LLC
SCHEDULE 13G · filed Aug 12, 2026 · Common stock, $0.001 par value per share
6.44%
D. E. Shaw & Co., L.P.
SCHEDULE 13G · filed Jul 2, 2026 · Common Stock, $0.001 par value per share
5.1%
Vanguard Capital Management
5.1%
Deerfield Mgmt, L.P.
SCHEDULE 13G/A · filed May 14, 2026 · Common Stock · reported falling below 5%, from 5.08% in Nov 13, 2025
under 5%
Fmr LLC
SCHEDULE 13G/A · filed Oct 7, 2025 · COMMON STOCK · reported falling below 5%, from 8.3% in Feb 12, 2025
under 5%
Kenneth Griffin
SCHEDULE 13G/A · filed Feb 17, 2026 · Common Stock, par value $0.001 per share (the "Shares") · reported falling below 5%, from 5.8% in Oct 6, 2025
under 5%
Wasatch Advisors LP
SCHEDULE 13G/A · filed Nov 12, 2025 · COM · reported falling below 5%, from 5.1% in May 13, 2025
under 5%
The Vanguard Group
SCHEDULE 13G/A · filed Mar 27, 2026 · Common Stock · reported falling below 5%
under 5%
Marc Stad
SCHEDULE 13G/A · filed Nov 14, 2025 · Common stock, par value $0.001 per share · reported falling below 5%, from 8% in Aug 14, 2025
under 5%
What INSP reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Private Company One
An investee · investee · invested in, named in the 10-K filed Feb 13, 2026
Insider tradesForm 4
7sales
0purchases
4sales on a scheduled plan
3people selling
$700,000sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 16, 2025 to Oct 16, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
181920212223242526
2026 runs to Oct 16, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window3 of 48 on the roster
PersonRole as filedSalesSoldOn a planBuysBought
Mccormick Shawndirector3$500,00030$0
Rondoni JohnTitle: Chief Product and Innovation Officer.3$200,00010$0
Kelly Jason PTitle - Chief Operations and Innovation Officer1$100,00000$0
SI Assistanton INSP · research, not advice